Claim OwnershipAddiction Medicine: Beyond the Abstract
Subscribed: 113Played: 1,690
Subscribe
© Copyright 2022. All rights reserved.
Description
Learn more about the perspectives behind formal research articles! In Journal of Addiction Medicine: Beyond the Abstract, hosts Shawn McNeil and Zach Caruso interview authors recently published in the Journal of Addiction Medicine, detailing their research process, summarizing key findings from their work, and identifying future areas of research.
Hosted by Journal Podcast Editor, Shawn McNeil, MD, and ASAM Media Manager Zach Caruso.
51 Episodes
Reverse
Journal of Addiction Medicine
In episode seventeen of Addiction Medicine: Beyond the Abstract, we are joined by Kathleen Carroll, PhD. She is the Albert E. Kent Professor of Psychiatry at Yale University School of Medicine. In her paper, Dr. Carroll discusses the feasibility of implementing computer-based treatments for substance use disorders in primary care settings.
In episode sixteen of Addiction Medicine: Beyond the Abstract, we are joined by Itai Danovitch, MD, MBA. He is the chairman of the Department of Psychiatry and Behavioral Neurosciences at Cedars-Sinai Medical Center in Los Angeles. In his paper, Dr. Danovitch discusses some of the challenges facing the study of opioid overdose events in the hospital setting.
To learn more, click here.
In episode fifteen of Addiction Medicine: Beyond the Abstract, we are joined by Dr. Tricia Wright, MD, MS, FACOG, DFASAM. She is a professor of clinical medicine at the University of California San Francisco. In her recent commentary, Dr. Wright discusses some of the challenges facing women in opioid treatment programs and the need for the provision of reproductive healthcare to this population.
To learn more, click here.
In episode fourteen of Addiction Medicine: Beyond the Abstract, we are joined by Dr. Babak Tofighi. He is an assistant professor in the departments of medicine and population health at the NYU School of Medicine. In his recent article, Dr. Tofighi discusses the use of technology-based interventions to optimize the treatment of substance use disorders (SUDs) and related comorbidities.
To read more, click here.
In episode thirteen of Addiction Medicine: Beyond the Abstract, we are joined by Dr. Jessica Gray. She is a family medicine physician and an addiction specialist in the departments of Medicine at Massachusetts General Hospital (MGH) and Pediatrics at Massachusetts General Hospital for Children (MGHfC). She is also Associate Program Director for the MGH Addiction Medicine Fellowship and Clinical Director of the HOPE Clinic at MGH. In her recent article, Dr. Gray discusses a case of a woman who was able to continue opioid agonist treatment during the postpartum period while she remained incarcerated, in a system that generally did not allow for opioid agonist treatment during incarceration except during pregnancy.
To learn more, click here.
In episode twelve of Addiction Medicine: Beyond the Abstract, we are joined by Dr. Hendrée Jones, a professor in the Department of Obstetrics and Gynecology at the University of North Carolina and the Director of UNC Horizons Program. In her recent article, Dr. Jones and her colleagues discuss the treatment of women in opioid use treatment programs in North Carolina and their utilization of reproductive and sexual health services.
To read the article, click here.
1In episode eleven of Addiction Medicine: Beyond the Abstract, we are joined by Dr. Honora Englander, an Associate Professor of Medicine at Oregon Health & Science University and the Director and Principal Investigator of the Improving Addiction Care Team (IMPACT). In her recent article, Dr. Englander and her colleagues discuss using hospitalization as a "reachable moment" for highly vulnerable patients who are not engaged in treatment elsewhere and utilizing the IMPACT team in this process.
To read more, click here.
In episode ten of Addiction Medicine: Beyond the Abstract, we are joined by Dr. Caleb Banta-Green, principal research scientist at The Alcohol and Drug Abuse Institute at the University of Washington. In his recent study, Dr. Banta-Green and his colleagues surveyed syringe exchange program (SEP) clients to gauge interest in receiving help with cessation or reduction of opiate use. Data from this study produced valuable conclusions about subgroups that are more likely to take advantage of available interventions.
Read more here.
In episode nine of Addiction Medicine: Beyond the Abstract, we are joined by Dr. John McCarthy, an associate professor of psychiatry and volunteer clinical faculty at the University of California Davis. In his recent study, Dr. McCarthy and his colleagues examined the significance of serum methadone/metabolite ratios (or MMRs). In particular, they looked at the changes in these ratios for the expecting mother throughout pregnancy and sought to use these ratios to objectively guide methadone dosing.
To read the full article, click here.
In episode eight of Addiction Medicine: Beyond the Abstract, we are joined by Dr. Lisa Marsch. She is a professor at Dartmouth and Director of both the Center for Technology and Behavioral Health and the Dartmouth Psychiatric Research Center. In her recent study, Marsch and her colleagues took a look at relevant randomized controlled trials and observational studies which evaluated the use of buprenorphine in adolescents and young adults.
To learn more, click here.
In episode seven of Addiction Medicine: Beyond the Abstract, we are joined by Barrett Raymond. He is a nurse practitioner and graduate of Brigham Young University. In his recent study, Raymond analyzed e-cigarette liquid samples from popular online manufacturers and distributors in the United States. He compared the expected nicotine content with the measured levels. He also discussed regulatory changes and the potential impact on the industry.
To read the full article, click here.
In episode six of Addiction Medicine: Beyond the Abstract, we are joined by Kelly Moore, Ph.D. of Yale University School of Medicine. Her new study takes a look at the implementation of continued methadone maintenance treatment (MMT) upon incarceration. Often, inmates undergo forced withdrawal once they are placed in a correctional setting. Her study sought to measure the difference in behavior both during incarceration and after release for inmates in a methadone maintenance group compared to those in a forced withdrawal group.
To read the article, click here.
In episode five of Addiction Medicine: Beyond the Abstract, we are joined by Leo Beletsky, JD, MPH of Northeastern University. His commentary from the latest issue of the journal addresses common challenges that influence the delivery of substance use treatment in the primary care setting. He details underlying concepts of behavioral economics that may impact the decisions made by healthcare providers. Specifically, he addresses choice architecture as it relates to decisions regarding substance use treatment.
Read more here.
In episode three of Addiction Medicine: Beyond the Abstract, we are joined by Dr. Sarah Bagley of Boston Medical Center and Boston University School of Medicine. Her recent commentary addresses the approach clinicians take in treating adolescents with opioid use disorder and perceptions about the use of medication management. She also discusses the recent policy statement by the American Academy of Pediatrics concerning the use of pharmacotherapy with buprenorphine/naloxone, methadone, and naltrexone in this population.
Read more here.
In episode two of Addiction Medicine: Beyond the Abstract, we are joined by Dr. Stefan Kertesz of the University of Alabama Birmingham and the Birmingham VA Medical Center. In his recent piece from the Journal, Dr. Kertesz discusses the challenge of treating patients who obtain benzodiazepines from another provider in addition to known prescribed opiates. He addresses this issue in the context of the results from a recent study by McClure, et al. in the same issue of the Journal which analyzes patterns of urine drug test results from a national laboratory.
Read more here.
ASAM developed the Appropriate Use of Drug Testing in Clinical Addiction Medicine document to provide guidance about the effective use of drug testing in the identification, diagnosis, treatment and promotion of recovery for patients with, or at risk for, addiction. Click here.
In this episode of Addiction Medicine: Beyond the Abstract, we are joined by Dr. Daniel Alford of Boston Medical Center and Boston University School of Medicine. His new study takes a closer look at the continuation of opiate agonist treatment in the perioperative setting among women undergoing cesarean section. Dr. Alford talks about the study, its limitations and applicability, and how the findings compare to current trends in practice. He also discusses his career in studying and treating patients with these issues.
In this episode, Dr. Nicolas Garel joins the podcast to discuss findings from his new article in the September/October issue of the Journal of Addiction Medicine titled Increased Risks of Major Cardiac Adverse Events in Stimulant Use Disorder as Compared With Other Substance Use Disorders: A Propensity-score Matching Cohort Study.
Dr. Nicolas Garel is a psychiatrist and clinician-scientist at the Centre Hospitalier de l’Université de Montréal (CHUM). He is an assistant professor in the Department of Psychiatry at the Université de Montréal and adjunct professor in the Department of Psychiatry and Behavioral Sciences at Stanford University. Dr. Garel completed his medical degree at the Université de Montréal, followed by his psychiatry residency and clinician-scientist fellowship at McGill University, and later pursued advanced training in research and addiction medicine at Stanford University. His research program focuses on innovative interventions for treatment-resistant mood disorders and substance use disorders.
Article Link: Increased Risks of Major Cardiac Adverse Events in Stimulant Use Disorder as Compared With Other Substance Use Disorders: A Propensity-score Matching Cohort Study
In this episode, Dr. Blythe Bynum joins the show to discuss her new article titled Navigating Choices: Pregnancy Options Counseling Experiences in Individuals With Opioid Use Disorder, featured in the November/December issue of the Journal of Addiction Medicine.
Dr. Blythe Bynum is an assistant professor in the Department of Obstetrics and Gynecology at Thomas Jefferson University in Philadelphia, Pennsylvania. She is a board certified OBGYN with fellowship training in Complex Family Planning.
Article Link: Navigating Choices: Pregnancy Options Counseling Experiences in Individuals With Opioid Use Disorder
In this episode, Dr. Bradley Stein joins the show to discuss findings from his new study titled Medicaid Unwinding: Association With New and Ending Buprenorphine Treatment Episodes, featured in the September/October issue of the Journal of Addiction Medicine.
Dr. Bradley Stein is a practicing physician and senior physician policy researcher at RAND. His research career has focused on improving access to, quality of, and outcomes from care of individuals with mental health and substance use disorders being treated in community settings. For two decades, Dr. Stein has studied the opioid crisis, serving as principal investigator for numerous federally and privately funded studies. He has published multiple peer-reviewed articles related to studies of opioid use disorder treatment, harm reduction, and the effects of state and federal policies, and he has provided Congressional testimony related to his research on multiple occasions. And his work has been covered by a range of media outlets including the Economist, Washington Post, and New York Times.
Article Link: Medicaid Unwinding: Association With New and Ending Buprenorphine Treatment Episodes
Guest Editorial: Medicaid Unwinding May Have Substantially Disrupted Buprenorphine Treatment
In this episode, Dr. Vinit Patel sits down to discuss his new article Non-medical Mephentermine Use: A Systematic Review of Literature, as well as what exactly mephentermine is, why and how it is currently being used in non-medical settings specifically in India and South Asia, and some of the contributing factors associated with geographic disparities in non-medical mephentermine use.
Article Link: Non-medical Mephentermine Use: A Systematic Review of Literature
Comments
Download from Google Play
Download from App Store
United States